BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 35482720)

  • 1. Comprehensive analysis of GSEC/miR-101-3p/SNX16/PAPOLG axis in hepatocellular carcinoma.
    Hu S; Zhang J; Guo G; Zhang L; Dai J; Gao Y
    PLoS One; 2022; 17(4):e0267117. PubMed ID: 35482720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Hypoxia-Related Prognostic Signature and Competing Endogenous RNA Regulatory Axes in Hepatocellular Carcinoma.
    Tang Y; Zhang H; Chen L; Zhang T; Xu N; Huang Z
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Analysis of Competing Endogenous RNA Network Focusing on Long Noncoding RNA Involved in Cirrhotic Hepatocellular Carcinoma.
    Zhang Y; Chen D; Yang M; Qian X; Long C; Zheng Z
    Anal Cell Pathol (Amst); 2021; 2021():5510111. PubMed ID: 34258170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of the MIR4435-2HG/miR-1-3p/MMP9/miR-29-3p/DUXAP8 ceRNA network axis in hepatocellular carcinoma.
    Zhang L; Hu S; Chen J; Ma S; Liu F; Liu C; Gao Y
    Discov Oncol; 2021 Oct; 12(1):38. PubMed ID: 35201491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of the competing endogenous circRNA-lncRNA-miRNA-mRNA network and identification of a novel potential biomarker for hepatocellular carcinoma.
    Zhang L; Tao H; Li J; Zhang E; Liang H; Zhang B
    Aging (Albany NY); 2021 May; 13(12):15990-16008. PubMed ID: 34049287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Integrated analysis of DNA methylation and gene expression profiles of hepatocellular carcinoma to construct miR-1180-3p relevant ceRNA regulatory network].
    Zhou ZH; Zhou XG; Zhou ZW; Qiu MQ; Jiang YJ; Lin QL; Liu YC; Wen QP; Huo RR; Liang XM; Yu HP
    Zhonghua Gan Zang Bing Za Zhi; 2020 Jun; 28(6):481-487. PubMed ID: 32660176
    [No Abstract]   [Full Text] [Related]  

  • 7. Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.
    Lin P; Wen DY; Li Q; He Y; Yang H; Chen G
    Cell Physiol Biochem; 2018; 48(5):1953-1967. PubMed ID: 30092571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analysis of a ceRNA network reveals potential prognostic cytoplasmic lncRNAs involved in HCC progression.
    Bai Y; Long J; Liu Z; Lin J; Huang H; Wang D; Yang X; Miao F; Mao Y; Sang X; Zhao H
    J Cell Physiol; 2019 Aug; 234(10):18837-18848. PubMed ID: 30916406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of microRNA hsa-miR-30c-5p as an inhibitory factor in the progression of hepatocellular carcinoma and investigation of its regulatory network via comprehensive analysis.
    Hu S; Zhang J; Fang X; Guo G; Dai J; Sheng Z; Li D; Chen J; Zhang L; Liu C; Gao Y
    Bioengineered; 2021 Dec; 12(1):7165-7177. PubMed ID: 34503377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of a ceRNA Network and Comprehensive Analysis of lncRNA in Hepatocellular Carcinoma.
    Wang L; Zhao J; Zhu C; Yang K; Zhu L; Liu Y
    Genes (Basel); 2022 Apr; 13(5):. PubMed ID: 35627170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel ceRNA axis involves in regulating immune infiltrates and macrophage polarization in gastric cancer.
    Nie K; Zheng Z; Wen Y; Pan J; Liu Y; Jiang X; Yan Y; Jiang K; Liu P; Xu S; Liu F; Li P
    Int Immunopharmacol; 2020 Oct; 87():106845. PubMed ID: 32763781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive analysis of a TPX2-related TRHDE-AS1/PKIA ceRNA network involving prognostic signatures in Hepatitis B virus-infected hepatocellular carcinoma.
    Li G; Wang Z; Chen D; Yin J; Mo Z; Sun B; Yang T; Zhang X; Zhai Z; Li Y; Chen P; Dai Y; Wang Z; Ma J
    Front Cell Infect Microbiol; 2022; 12():1025900. PubMed ID: 36204642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated analysis of ceRNA network reveals potential prognostic Hint1-related lncRNAs involved in hepatocellular carcinoma progression.
    Zhang C; Bao T; Ke Y; Liu X; Wang X; Liao W; He Y; Wang L
    World J Surg Oncol; 2022 Mar; 20(1):67. PubMed ID: 35241097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ceRNA network development and tumor-infiltrating immune cell analysis in hepatocellular carcinoma.
    Chen L; Zou W; Zhang L; Shi H; Li Z; Ni C
    Med Oncol; 2021 Jun; 38(7):85. PubMed ID: 34148185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulated UBE4B expression correlates with poor prognosis and tumor immune infiltration in hepatocellular carcinoma.
    Shao X; Zhu J; Shi Y; Fang H; Chen J; Zhang Y; Wang J; Jian H; Lan S; Jiang F; Zhong F; Zhang Y; Cao C
    Aging (Albany NY); 2022 Dec; 14(23):9632-9646. PubMed ID: 36470669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Four Autophagy-Related lncRNAs Predict the Prognosis of HCC through Coexpression and ceRNA Mechanism.
    Wu H; Liu T; Qi J; Qin C; Zhu Q
    Biomed Res Int; 2020; 2020():3801748. PubMed ID: 33102579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of a ceRNA network and a genomic-clinicopathologic nomogram to predict survival for HBV-related HCC.
    Huang K; Lu Z; Li L; Peng G; Zhou W; Ye Q
    Hum Cell; 2021 Nov; 34(6):1830-1842. PubMed ID: 34487338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of an immune-related ceRNA network in identifying a novel lncRNA signature as a prognostic biomarker for hepatocellular carcinoma.
    Chen R; Chen Y; Huang W; Zhao Y; Luo W; Lin J; Wang Z; Yang J
    Aging (Albany NY); 2021 Jul; 13(13):17607-17628. PubMed ID: 34237706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated analysis of ceRNA network in hepatocellular carcinoma using bioinformatics analysis.
    Luo Y; Li H; Huang H; Xue L; Li H; Liu L; Fu H
    Medicine (Baltimore); 2021 Jun; 100(22):e26194. PubMed ID: 34087888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of
    Luo H; Jiang Q; Luo Y; Yang M; Yu Y; Yu C; Wang X
    Epigenomics; 2022 Nov; 14(22):1393-1409. PubMed ID: 36695093
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.